Discovery of small molecules targeting the tandem tudor domain of the epigenetic factor UHRF1 using fragment-based ligand discovery
Abstract Despite the established roles of the epigenetic factor UHRF1 in oncogenesis, no UHRF1-targeting therapeutics have been reported to date. In this study, we use fragment-based ligand discovery to identify novel scaffolds for targeting the isolated UHRF1 tandem Tudor domain (TTD), which recogn...
Saved in:
Main Authors: | Lyra Chang, James Campbell, Idris O. Raji, Shiva K. R. Guduru, Prasanna Kandel, Michelle Nguyen, Steven Liu, Kevin Tran, Navneet K. Venugopal, Bethany C. Taylor, Matthew V. Holt, Nicolas L. Young, Errol L. G. Samuel, Prashi Jain, Conrad Santini, Banumathi Sankaran, Kevin R. MacKenzie, Damian W. Young |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/5972f93c7d5b4a20bcf0f3bca4897227 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Structural basis for recognition of 53BP1 tandem Tudor domain by TIRR
by: Yaxin Dai, et al.
Published: (2018) -
Discovery and quality analysis of a comprehensive set of structural variants and short tandem repeats
by: David Jakubosky, et al.
Published: (2020) -
Price Discovery of Consignment Auctions for Emission Permits
by: Jae-Do Song, et al.
Published: (2021) - Discovery (00123641)
- Drug Discovery